ASML's 7% Dip: Flow Metrics and TD Cowen's Buy Case

The recent pullback is a classic flow-driven reassessment. Shares have retreated roughly 7% from the February 25 high of $1,547.22, settling near $1,427.41. This correction follows a powerful rally fueled by a single, massive catalyst: Q4 bookings that exploded to EUR 13.2 billion. That figure more than doubled the consensus forecast, a clear signal of surging AI-driven capital expenditure.

TD Cowen's recent price target raise to EUR 1,500 underscores the fundamental flow story. The firm cited the bookings and forward guidance as core catalysts, noting management's view that ASML is not the bottleneck to customer capacity plans. This institutional confidence, backed by a record EUR 12 billion share buyback program, provides a structural floor to the stock's valuation.

The dip, therefore, appears to be a healthy consolidation after a parabolic move. The underlying flow metrics-record bookings, robust guidance, and aggressive capital return-remain intact. The market is simply digesting the valuation premium that followed the explosive order surge, not questioning the fundamental demand engine.

The Valuation Gap: Premium Flow vs. Premium Price

The market is paying a steep premium for ASML's monopoly flow. The stock trades at a P/E ratio of 47.89, a multiple justified by its EUV monopoly and scarcity value. This isn't a speculative bet on future growth; it's a direct valuation of current, unassailable market dominance. The flow story-record bookings, robust guidance, and aggressive capital return-supports this premium, but it also sets a very high bar for execution.

TD Cowen's EUR 1,500 price target implies roughly 7% upside from recent levels. Yet the stock is still just 1% below its 52-week high. This highlights the valuation gap: the firm sees room to run, but the market has already priced in a significant portion of the near-term thesis. The setup is one of high confidence meeting high expectations.

That confidence is widespread. 8 analysts have revised their earnings estimates upward for the upcoming period. This collective optimism reflects a belief that the powerful growth flows will continue to justify the premium. The risk is that any stumble in the flow-whether from a guidance miss or a slowdown in AI capex-could trigger a sharp re-rating, as the stock has little room for error at these levels.

Catalysts and Risks: The 2026 Capacity Expansion

The near-term flow catalyst is the execution of the 2026 outlook. Management's guidance for the year ranges from +4% to +19% growth, a wide band directly tied to immersion capacity and customers' ability to receive equipment. This sets up a clear binary for the stock: hitting the high end of the range would validate the premium, while missing it would pressure the valuation.

Management's critical flow assumption is that ASML is not the bottleneck to customers' capacity plans this year. This view, cited by TD Cowen, underpins the entire growth thesis. It implies that the primary constraint is now customer deployment speed, not ASML's production or shipping. The stock's premium is built on this belief in unimpeded flow.

The primary risk is demand softness or delays in the AI infrastructure build-out. Any slowdown in customer spending or capacity ramp would directly pressure the high end of the growth guidance. Given the stock's elevated multiple, even a modest miss in execution could trigger a sharp re-rating, as the market has little room for error at these levels.